ArticleBMC geriatrics2025
Evaluation of outcomes, costs, and feasibility of home-based geriatric rehabilitation after inpatient rehabilitation: study protocol of the "Better@Home" multicentre prospective cohort study with historical control group.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe increasing demands of an aging population, healthcare workforce shortages, financial constraints, and a shift in care perspectives call for rethinking geriatric rehabilitation (GR). To ensure GR remains sustainable, a transition towards home-based GR is proposed, reducing the need for prolonged inpatient GR. This study assesses the outcomes, costs and feasibility of the "Better@Home" program, in which home-based GR replaces part of inpatient GR.
methodsThis multicenter cohort study is conducted in eight GR facilities in the Netherlands, implementing the Better@Home program. Core elements of this program include replacing part of inpatient GR with home-based GR, focusing on participation goals, using eHealth, promoting self-management, and fostering close collaboration among all care partners. Data is gathered through semi-structured interviews, questionnaires, group interviews, registration forms, and electronic patient files. The Better@Home study is designed as a cohort study accompanied by a mixed-methods feasibility study. The study includes an outcome-and cost assessment. Within the cohort study, two evaluations can be distinguished. The first is a comparative evaluation, comparing the multicentre prospective Better@Home cohort with a historical control group on the primary outcome measure, as well as patient, family, and healthcare-related costs, from admission to completion of GR. The primary outcome measure of the comparative evaluation is independence in activities of daily living, assessed by the Barthel Index. The second is a follow-up evaluation, to assess the course of the outcomes and costs from GR admission to three months of follow-up after GR completion, solely in the Better@Home cohort. The primary outcome measure of the follow-up evaluation is participation, assessed by the Canadian Occupational Performance Measure. The mixed-methods feasibility study incorporates both quantitative and qualitative methods. It evaluates the program's reach, performance according to plan, active engagement of patients and informal caregivers, barriers and facilitators affecting implementation, and the opinions of patients, informal caregivers, and professionals on the program. DISCUSSION: This study offers insights into the potential of home-based GR. The multicentre and multilayered design enables a comprehensive evaluation of the Better@Home program's outcomes, costs and feasibility, providing a basis for further optimization and upscaling of home-based GR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.